There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Rescue workers are at the site Sunday morning trying to cut open mangled coaches.
Despite chilly temperatures it will be a mostly dry day, and milder than yesterday.
The Sunday Times alleges a missile malfunctioned after launch during a routine test of the UK's nuclear deterrent last year.